ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

STAA STAAR Surgical Company

46.96
0.07 (0.15%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
STAAR Surgical Company NASDAQ:STAA NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.07 0.15% 46.96 46.60 47.38 48.02 46.43 47.14 335,626 00:18:01

Current Report Filing (8-k)

03/05/2019 3:27pm

Edgar (US Regulatory)


U N IT E D S T A T ES

S E C U R IT I E S A N D E X CHA N GE CO M MISSION

WAS H IN G TON, DC 2 0549

 

 

FORM 8-K

 

CURRENT REPORT

P u r s u a n t t o S e c tion 13 or 15(d) of t h e S ec u r ities Excha n ge A c t of 1934

 

Da t e of re p o r t ( D a t e of e a r l i e st e v e n t r e p o r t e d) : May 1, 2019

 

 

STAAR Surgical Company

( Ex act N a m e of Re g i s trant a s S p ecified i n Charter)

 

 

Delaware

0-11634

95-3797439

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

 

 

 

1911 Walker Ave.,

Monrovia, California

 

91016

(Address of Principal Executive Offices)

 

(Zip Code)

Registrant’s Telephone Number, Including Area Code: 626-303-7902

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Che c k t he a ppropr iate bo x b e l o w i f the F o r m 8 - K f il i n g is i n ten d ed to s i mult a ne o u sl y sati s f y t he f il i ng ob l i gati o n o f the r egistr a nt un d er a n y o f t he f o ll o w i n g pro visi o ns ( s ee G e ne r al I n s tructi o n A . 2 . b el o w ) :

 

Wr itten c o mm u n icati o n p u r s u a n t to R u le 42 5 un d er t h e Se c u r ities A ct (1 7 C F R 230 . 4 2 5 )

 

S o liciting m ate r ial p u r s u a n t to Ru le 14 a - 1 2 u n d er t h e E x c h a ng e A ct (1 7 C F R 240 . 14 a - 12)

 

P re - c o mm e n c e m e n t c o m m u n i c a ti o n p u r s u a n t to Ru le 14 d - 2(b ) un d er t h e E x c h a n g e A ct (1 7 C FR 240 . 14 d - 2( b ) )

 

P re - c o mm e n c e m e n t c o m m u n i c a ti o n p u r s u a n t to Ru le 13 e - 4 ( c) un d er t h e E x c h a ng e A c t (1 7 C FR 240 . 13 e - 4( c ) )

 

 

I n dicate b y c h e c k m a r k w h e ther t h e re g i s tr a n t is a n e m er g i ng g r o w t h c o m pany as defi n ed in R u le 405 of t h e Se c u rities A ct o f 1 933 (17 C FR §230 . 405) or Ru le 1 2 b - 2 of t h e Se c u rities E x c han g e A ct of 1934 (17 C FR §240 . 1 2 b - 2).

E m e r g i n g g r o w t h c o m p a n y

 

If an e m er g i ng g r o w th c o m p a n y , i n dicate b y c h e c k m ark i f t h e re g istra n t h as elected n ot to us e t h e e x t e n ded tra ns i t ion period f or co m p l y i n g w i th a ny n e w or re v i s ed f i n a n cial accou n t i ng s t a n da r ds pro v ided p u r su a n t to S ection 13(a) of t h e E x c h a n g e A ct.

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common

STAA

NASDAQ

 



Item 7.01 Regulation FD Disclosure.

 

On May 1, 2019, the Company held a conference call to discuss the financial results for the quarter ended March 29, 2019.  A transcript of the conference call is furnished as Exhibit 99.1 to this report and is incorporated herein by this reference.

 

The information furnished herewith pursuant to Item 7.01 of this Current Report, including Exhibit 99.1, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information in Item 7.01 of this Current Report shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in the filing.

 

 

Item 9.01 Financial Statements and Exhibits

 

Exhibit No.

 

Description

99.1

 

Transcript of conference call of the Company held on May 1, 2019

 

 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

STAAR Surgical Company 

 

May 2, 2019

By:

/s/ Caren Mason

 

 

Caren Mason

 

 

President and Chief Executive Officer

 

 

 

1 Year STAAR Surgical Chart

1 Year STAAR Surgical Chart

1 Month STAAR Surgical Chart

1 Month STAAR Surgical Chart

Your Recent History

Delayed Upgrade Clock